MedPath

Emotional Dysregulation in Adult ADHD.

Not Applicable
Active, not recruiting
Conditions
Adult ADHD
Interventions
Other: Neuropsychological testing
Other: Actimetry
Other: Self-questionnaires on emotional topics
Registration Number
NCT03494478
Lead Sponsor
University Hospital, Strasbourg, France
Brief Summary

Attention deficit disorder in adults with or without hyperactivity (ADHD) is a common disorder, affecting around 3% of the population. ADHD increases the risk of psychiatric disorders (mood disorders, sleep disorders, personality disorders, addictive behavior), risky behaviors, and vocational difficulties. Emotional dysregulation (ED) constitute a major hindrance in the daily life of subjects, with a great impact on the general functioning and the quality of life of the patients.

The investigators want to determine the characteristics of patients with each type of ED (impulsivity, exacerbated emotional intensity, cyclothymia, borderline personality traits), and study the stability of these traits over time. Since circadian rhythms influence mood and circadian rhythms frequently occur in patients with ADHD, the investigators want to determine if there is a link between ED and instability in circadian rhythms. Finally, they would like to observe whether the ED evolves and according to whether or not treatment is taken

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
120
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Cohort groupActimetryAll participants will have evaluations at inclusion and 12 months. Neuropsychological testing Actimetry Selfquestionnaires on emotional topics
Cohort groupNeuropsychological testingAll participants will have evaluations at inclusion and 12 months. Neuropsychological testing Actimetry Selfquestionnaires on emotional topics
Cohort groupSelf-questionnaires on emotional topicsAll participants will have evaluations at inclusion and 12 months. Neuropsychological testing Actimetry Selfquestionnaires on emotional topics
Primary Outcome Measures
NameTimeMethod
Characterization of emotional dysregulation (descriptive analysis of different scales assessing emotional dysregulation)At 12 months after inclusion

Score of borderline personality symptoms (BSL scale)

Secondary Outcome Measures
NameTimeMethod
Association between emotional dysregulation, cognitive deficits and circadian instabilityAt 12 months after inclusion

Correlation between emotional dysregulation and executive and attentional dysfunction measured with the TAP test.

Correlation between emotional dysregulation and instability index of circadian rhythms measured by actimetry.

Trial Locations

Locations (2)

Centre Hospitalier Spécialisé de Rouffach - Secteur 8

🇫🇷

Rouffach, France

Hôpitaux Universitaires de Strasbourg - Service de Psyhciatrie 2/PPSAM

🇫🇷

Strasbourg, France

© Copyright 2025. All Rights Reserved by MedPath